EUVIMEDEUVIMED entdecken
Crossref

Enterovirus D68: A Novel Inhibitor Reveals Underlying Molecular Mechanisms of Viral Entry and Uncoating

Huu Y Le iD, Wen-Fang Tang, Yann-Lii Leu, Minh Hai Nguyen, Dinh Tien Nguyen, Thi Duyen Thi, Tran Thao Vy Le, Muhamad Sahlan, Chyi-Liang Chen, Shu-Min Lin, Jim-Tong Horng iD

Journal of Medical Virology · 2025

DOI: 10.1002/jmv.70677 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2025. Verfasst von Huu Y Le und 10 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan. Hauptthemen laut MEDLINE: Virus Internalization, Enterovirus D, Human, Antiviral Agents, Virus Uncoating. Die Arbeit nennt 49 Literaturangaben. Gefördert von: This study was supported by the National Science and Technology Council (NSTC), Taiwan, under grants NSTC 113-2321-B-182-003, 113-2320-B-182-012, 112-2320-B-18….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

While enterovirus D68 (EV‐D68) has emerged as a significant pediatric pathogen causing severe respiratory illness and acute flaccid myelitis, no effective therapeutics exist. Through systematic screening of natural products, we identified geranyl‐ p ‐trans‐coumaric acid (GCA) as a potent EV‐D68 inhibitor with EC 50 values of 20‒40 μM against multiple clinical strains. Time‐of‐addition analysis revealed that GCA primarily targets early viral entry processes, with strongest inhibition during the adsorption phase. Mechanistic investigations demonstrated that GCA directly binds to EV‐D68 particles and prevents viral uncoating without interfering with initial cellular attachment. Thermal protection and PaSTRy assays confirmed GCA‐mediated capsid stabilization, increasing RNA release temperature from 51°C to 53°C. Receptor binding studies showed that GCA selectively inhibits virus interaction with heparan sulfate proteoglycans but not ICAM‐5, indicating specific interference with secondary receptor engagement. Resistance selection identified critical mutations in VP1 (T92N) and nonstructural protein 2 C (K6R), with resistance requiring both mutations simultaneously, suggesting cooperative dual‐targeting mechanisms. Molecular docking revealed GCA binding to the VP1 canyon region, and combination studies with pleconaril demonstrated synergistic effects (combination index = 0.83). Single mutations alone maintained drug sensitivity, but double mutants exhibited marked resistance (EC 50 > 200 μM), confirming dual targeting of viral capsid and cellular host factors. In vivo efficacy studies demonstrated dose‐dependent protection, with 71% survival at 12 mg/kg/day compared to 18% in controls ( p < 0.01) and significant viral burden reduction in brain and muscle tissues. These findings identify GCA as a promising therapeutic candidate against EV‐D68 operating through novel dual mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Virus InternalizationEnterovirus D, HumanAntiviral AgentsVirus UncoatingHumansEnterovirus InfectionsAnimalsMiceCapsid ProteinsDrug Resistance, Viral

Stichwörter der Autor:innen

Enterovirus D68Geranyl‐p‐trans‐coumaric acidcapsid bindingviral Uncoatingviral entry

Substanzen

Antiviral AgentsCapsid Proteins

Autor:innen und Institutionen

  • Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
  • Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
  • Department of Respiratory Diseases, 108 Military Central Hospital, Hanoi, Vietnam.
  • Department of Biochemistry and Molecular Biology, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
  • Research Center for Emerging Viral Infections, College of Medicine, Taoyuan, Taiwan.
  • Graduate Institute of Natural Products, College of Medicine, Chang Gung University, Taoyuan, Taiwan.

ORCID-Profile: Huu Y Le, Jim-Tong Horng

Förderung

  • This study was supported by the National Science and Technology Council (NSTC), Taiwan, under grants NSTC 113-2321-B-182-003, 113-2320-B-182-012, 112-2320-B-18…

Zitieren

APA

Le, H. Y., Tang, W. F., Leu, Y. L., Nguyen, M. H., Nguyen, D. T., Duyen Thi, T., Le, T. T. V., Sahlan, M., Chen, C. L., Lin, S. M., & Horng, J. T. (2025). Enterovirus D68: A Novel Inhibitor Reveals Underlying Molecular Mechanisms of Viral Entry and Uncoating. Journal of Medical Virology. https://doi.org/10.1002/jmv.70677

Vancouver

Le HY, Tang WF, Leu YL, Nguyen MH, Nguyen DT, Duyen Thi T, et al. Enterovirus D68: A Novel Inhibitor Reveals Underlying Molecular Mechanisms of Viral Entry and Uncoating. Journal of Medical Virology. 2025. doi:10.1002/jmv.70677

BibTeX
@article{Le2025,
  author = {Le, Huu Y and Tang, Wen-Fang and Leu, Yann-Lii and Nguyen, Minh Hai and Nguyen, Dinh Tien and Duyen Thi, Thi and Le, Tran Thao Vy and Sahlan, Muhamad and Chen, Chyi-Liang and Lin, Shu-Min and Horng, Jim-Tong},
  title = {Enterovirus D68: A Novel Inhibitor Reveals Underlying Molecular Mechanisms of Viral Entry and Uncoating},
  journal = {Journal of Medical Virology},
  year = {2025},
  doi = {10.1002/jmv.70677}
}
Kostenlos starten →